INZY
Price
$3.99
Change
-$0.01 (-0.25%)
Updated
Jun 27 closing price
Capitalization
257.6M
44 days until earnings call
TLPPF
Price
$15.80
Change
-$0.35 (-2.17%)
Updated
Jun 27 closing price
Capitalization
5.34B
Interact to see
Advertisement

INZY vs TLPPF

Header iconINZY vs TLPPF Comparison
Open Charts INZY vs TLPPFBanner chart's image
Inozyme Pharma
Price$3.99
Change-$0.01 (-0.25%)
Volume$4.96M
Capitalization257.6M
Telix Pharmaceutical
Price$15.80
Change-$0.35 (-2.17%)
Volume$2K
Capitalization5.34B
INZY vs TLPPF Comparison Chart in %
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INZY vs. TLPPF commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Buy and TLPPF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (INZY: $3.99 vs. TLPPF: $15.80)
Brand notoriety: INZY and TLPPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 178% vs. TLPPF: 33%
Market capitalization -- INZY: $257.6M vs. TLPPF: $5.34B
INZY [@Biotechnology] is valued at $257.6M. TLPPF’s [@Biotechnology] market capitalization is $5.34B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 0 FA rating(s) are green whileTLPPF’s FA Score has 1 green FA rating(s).

  • INZY’s FA Score: 0 green, 5 red.
  • TLPPF’s FA Score: 1 green, 4 red.
According to our system of comparison, both INZY and TLPPF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 3 TA indicator(s) are bullish while TLPPF’s TA Score has 3 bullish TA indicator(s).

  • INZY’s TA Score: 3 bullish, 2 bearish.
  • TLPPF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, INZY is a better buy in the short-term than TLPPF.

Price Growth

INZY (@Biotechnology) experienced а 0.00% price change this week, while TLPPF (@Biotechnology) price change was -5.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

INZY is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLPPF($5.34B) has a higher market cap than INZY($258M). INZY YTD gains are higher at: 44.043 vs. TLPPF (5.509). TLPPF has higher annual earnings (EBITDA): 92.5M vs. INZY (-100.34M). TLPPF has more cash in the bank: 710M vs. INZY (84.8M). INZY has less debt than TLPPF: INZY (47M) vs TLPPF (581M). TLPPF has higher revenues than INZY: TLPPF (783M) vs INZY (0).
INZYTLPPFINZY / TLPPF
Capitalization258M5.34B5%
EBITDA-100.34M92.5M-108%
Gain YTD44.0435.509799%
P/E RatioN/A167.54-
Revenue0783M-
Total Cash84.8M710M12%
Total Debt47M581M8%
FUNDAMENTALS RATINGS
TLPPF: Fundamental Ratings
TLPPF
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
17
SMR RATING
1..100
73
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INZYTLPPF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
65%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
66%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
64%
Advances
ODDS (%)
Bullish Trend 17 days ago
87%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XTL116.320.70
+0.61%
SPDR® S&P Telecom ETF
QQLV24.810.08
+0.31%
Invesco QQQ Low Volatility ETF
MLPX62.44-0.02
-0.03%
Global X MLP & Energy Infrastructure ETF
HTAB18.67-0.07
-0.37%
Hartford Schroders Tax-Aware Bond ETF
UTHY41.40-0.27
-0.66%
US Treasury 30 Year Bond ETF

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with ACAD. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then ACAD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-0.25%
ACAD - INZY
50%
Loosely correlated
-0.41%
KROS - INZY
43%
Loosely correlated
-0.15%
PRME - INZY
40%
Loosely correlated
-8.68%
AURA - INZY
38%
Loosely correlated
-0.16%
NGNE - INZY
38%
Loosely correlated
-2.47%
More

TLPPF and

Correlation & Price change

A.I.dvisor tells us that TLPPF and BDTX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPPF and BDTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPPF
1D Price
Change %
TLPPF100%
-2.17%
BDTX - TLPPF
22%
Poorly correlated
-4.07%
ITOS - TLPPF
21%
Poorly correlated
-0.70%
RCUS - TLPPF
21%
Poorly correlated
-6.47%
ORMP - TLPPF
21%
Poorly correlated
-0.92%
INZY - TLPPF
20%
Poorly correlated
-0.25%
More